CG
TFFP

Cutler Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Cutler Group’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40
Closed – – 4508
2023
Q3 		$0 Hold
40
– – ﹤0.01% 4447
2023
Q2 		$0 Hold
40
– – ﹤0.01% 4310
2023
Q1 		$0 Hold
40
– – ﹤0.01% 4896
2022
Q4 		$1K Hold
40
– – ﹤0.01% 4213
2022
Q3 		$4K Hold
40
– – ﹤0.01% 3876
2022
Q2 		$5K Hold
40
– – ﹤0.01% 3783
2022
Q1 		$6K Hold
40
– – ﹤0.01% 4060
2021
Q4 		$8K Sell
40
-11
-22% -$2.13K ﹤0.01% 3910
2021
Q3 		$9K Sell
51
-48
-48% -$10.2K ﹤0.01% 4068
2021
Q2 		$23K Buy
99
+55
+125% +$15.1K ﹤0.01% 3199
2021
Q1 		$14K Sell
44
-280
-86% -$114K ﹤0.01% 3532
2020
Q4 		$115K Buy
324
+300
+1,250% +$116K 0.01% 1435
2020
Q3 		$11K Buy
+24
New +$6.77K ﹤0.01% 2946

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cutler Group's TFFP Position: Q4 2023 in Review

Cutler Group sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 40 shares.

Cutler Group first reported a position in TFFP in Q3 2020 and held it in 13 quarters. The position peaked at $115K in Q4 2020. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Cutler Group reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 40 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023.
  • Cutler Group first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Cutler Group's TFF Pharmaceuticals, Inc. Common Stock position peaked at $115K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.